| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |